Musculo-skeletal disorders, Guidance

Applied filters

COVID-19 Vaccines (1)
- General information and guidance (1)
  - All vaccines: Answers to Questions (1)
Care Setting (1)
- Primary Care and PCNs (1)
- Trusts (1)
Guidance (97)
- Advanced therapy medicinal products (9)
- Cautions and contraindications (1)
- Dosing (3)
- Immunosuppressives (1)
- Safety in Breastfeeding (68)
- Stability in dosette boxes (58)
- Stability outside the fridge (20)
Medicine (87)
- Abatacept (1)
- Aceclofenac (1)
- Acemetacin (1)
- Adalimumab (1)
- Alendronic acid (1)
- Allopurinol (1)
- Amifampridine (1)
- Azathioprine (1)
- Baclofen (1)
- Belimumab (1)
- Bimekizumab (1)
- Calcitonin (1)
- Canakinumab (1)
- Capsaicin (1)
- Celecoxib (1)
- Certolizumab pegol (1)
- Chloroquine (1)
- Ciclosporin (1)
- Colchicine (1)
- Collagenase clostridium histolyticum (1)
- Dantrolene (1)
- Denosumab (1)
- Dexamethasone (1)
- Dexibuprofen (1)
- Dexketoprofen (1)
- Diazepam (1)
- Diclofenac potassium (1)
- Diclofenac sodium (1)
- Diclofenac sodium + Misoprostol (1)
- Dronabinol + Cannabidiol (1)
- Eculizumab (1)
- Edrophonium (1)
- Etanercept (1)
- Etidronate disodium (1)
- Etodolac (1)
- Etoricoxib (1)
- Fampridine (1)
- Febuxostat (1)
- Felbinac (1)
- Fenoprofen (1)
- Flurbiprofen (1)
- Glucosamine hydrochloride (1)
- Glucosamine sulfate (1)
- Golimumab (1)
- Hydroxychloroquine (1)
- Ibandronic acid (1)
- Ibuprofen (1)
- Indometacin (1)
- Infliximab (1)
- Kaolin (1)
- Ketoprofen (1)
- Leflunomide (1)
- Mefenamic acid (1)
- Meloxicam (1)
- Methocarbamol (1)
- Methotrexate (2)
- Mexiletine (1)
- Nabumetone (1)
- Naltrexone (1)
- Naproxen (1)
- Naproxen + Esomeprazole (1)
- Neostigmine (2)
- Ofatumumab (1)
- Penicillamine (1)
- Piroxicam (1)
- Piroxicam betadex (1)
- Probenecid (1)
- Pyridostigmine (2)
- Quinine (1)
- Rasburicase (1)
- Risedronate sodium (1)
- Rituximab (1)
- Sodium clodronate (1)
- Sodium cromoglicate (1)
- Sodium picosulfate (1)
- Sulfasalazine (1)
- Sulfinpyrazone (1)
- Sulindac (1)
- Tadalafil (1)
- Tenoxicam (1)
- Teriparatide (1)
- Tiaprofenic acid (1)
- Tizanidine (1)
- Tocilizumab (1)
- Ustekinumab (1)
Planning (45)
- Biosimilars (6)
- New Medicines (36)
  - CCG commissioned new medicines (19)
  - NHS England commissioned new medicines (23)
  - Pre-registration new medicines (UK/EU) (3)
- Patent expiries (27)
Specialty (97)
- Allergy and immunology (2)
- Anaesthesia and pain (27)
- Cancers (10)
- Cardiovascular system disorders (3)
- Ear, nose and throat disorders (3)
- Endocrine system disorders (7)
- Eyes and vision (7)
- Gastrointestinal disorders (8)
- Haematological disorders (2)
- Infection and infectious diseases (4)
- Mental health and illness (1)
- Musculo-skeletal disorders (97)
- Neurological disorders (4)
- Nutritional and metabolic disorders (1)
- Renal and urologic disorders (1)
- Respiratory disorders (1)
- Skin disorders (10)

GNT 0004

Spheroids of human autologous matrix-associated chondrocytes

SGT-001

Bidridistrogene xeboparvovec

Using COVID-19 vaccines in patients taking immunosuppressive medicines

22 January 2021National advice and considerations on the use of this vaccine in patients taking immunosuppressive medicines

Delandistrogene moxeparvovec

Fordadistrogene movaparvovec

How do you convert an oral pyridostigmine or neostigmine dose to a parenteral neostigmine dose?

23 April 2020This updated Medicines Q&A gives suggested dose conversions from oral pyridostigmine or neostigmine to parenteral neostigmine and includes example dose conversion calculations

Resamirigene bilparvovec

What is the evidence for low dose naltrexone for treatment of multiple sclerosis?

11 February 2020This updated Medicines Q&A evaluates the limited evidence available for low dose naltrexone for treatment of multiple sclerosis.

SPS - Specialist Pharmacy Service

NHS